Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Investigating Proliferative Cell Nuclear Antigen (PCNA) Modification as a Source of R-loops and Genome Instability in Cancer
EF 2017-18
Résumé
Cancer is a disease caused by mutations in normal DNA. High rates of mutations dubbed 'Genome instability' give rise to cancer, and can occur for many reasons. Environmental or endogenous damage to DNA can impair DNA replication. This replication stress can result in genome instability. Replication stress can also arise when RNA transcripts being made from DNA stick to the genome, creating a hybrid structure called an R-loop. The cell has several mechanisms to deal with R-loops but there are critical gaps in our knowledge in this area. I have already found that Rad18, a protein involved in the regulation of two types of genome maintenance pathways, is involved in R-loop prevention. Rad18 functions by modulating a DNA clamp called proliferative cell nuclear antigen (PCNA). My project will uncover the importance of Rad18 and its modification and subsequent loading/unloading of the PCNA clamp to R-loop related genome instability and cancer. The tools to evaluate R-loops, detect genome instability and assess protein-R-loop binding have been established in our lab and I am poised to deploy them in the study of Rad18 and PCNA modification. Existing cancer treatment strategies have targeted cancers that lack genome stability factors by further inducing replication stress to halt cancer cell growth. Thus, in addition to elucidating R-loop maintenance mechanisms, our work may provide insight to therapies that could target cancers with a high burden of R-loops.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386610
Name
Wells James P
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Proliferative Cell Nuclear Antigen (PCNA) Modification as a Source of R-loops and Genome Instability in Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cancer Therapy; Dna Damage; Fanconi Anemia Proteins; Genome Instability; Pcna; Post Replicative Repair; R-Loops; Rad18; Replication-Transcription Conflicts
Abstract
Cancer is a disease caused by mutations in normal DNA. High rates of mutations dubbed 'Genome instability' give rise to cancer, and can occur for many reasons. Environmental or endogenous damage to DNA can impair DNA replication. This replication stress can result in genome instability. Replication stress can also arise when RNA transcripts being made from DNA stick to the genome, creating a hybrid structure called an R-loop. The cell has several mechanisms to deal with R-loops but there are critical gaps in our knowledge in this area. I have already found that Rad18, a protein involved in the regulation of two types of genome maintenance pathways, is involved in R-loop prevention. Rad18 functions by modulating a DNA clamp called proliferative cell nuclear antigen (PCNA). My project will uncover the importance of Rad18 and its modification and subsequent loading/unloading of the PCNA clamp to R-loop related genome instability and cancer. The tools to evaluate R-loops, detect genome instability and assess protein-R-loop binding have been established in our lab and I am poised to deploy them in the study of Rad18 and PCNA modification. Existing cancer treatment strategies have targeted cancers that lack genome stability factors by further inducing replication stress to halt cancer cell growth. Thus, in addition to elucidating R-loop maintenance mechanisms, our work may provide insight to therapies that could target cancers with a high burden of R-loops.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wells, James P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~